Skip to main content

Volume 18 Supplement 1

19th Annual SCMR Scientific Sessions

  • Poster presentation
  • Open access
  • Published:

The right ventricular end-systolic volume index predicts mortality in patients with cardiac amyloidosis


Cardiac amyloidosis (CA) is generally characterized by a poor prognosis and significantly increased mortality. Although right ventricular (RV) dysfunction is strong predictor of outcome in AL amyloidosis, there are limited data regarding the prognostic significance of RV size. We sought to investigate whether cardiovascular magnetic resonance (CMR) assessment of RV size has prognostic value in CA.


Consecutive patients referred for CMR for possible CA were retrospectively evaluated. Diagnosis of CA was based on that all patients had positive Congo red staining of biopsy (periumbilical fat, rectum, kidney), and the presence of a typical pattern of subendocardial late gadolinium enhancement. The patients underwent CMR with measurement of left ventricular (LV) and RV volumes, mass and ejection fraction.


69 patients (41 males (59.4%), age 60 ± 11 years) were included, CA was diagnosed in 47 (68.1%). Age, gender, New York Heart Association class, medications, serological biomarkers, and electrocardiographic voltage were recorded. The parameters measured by MRI were also recorded, such as the left ventricular end-diastolic volume (LVEDV), the right ventricular end-diastolic volume (RVEDV), the left ventricular mass (LV mass). Mean age was 61 ± 10 years with 28 men (59.5%) in CA. New York Heart Association class >II was noted in 24 patients (51.1%) and low voltage on electrocardiogram (QRS amplitude of ≤0.5 mV in all limb leads or ≤1 mV in all precordial leads) in 23(48.9%). At a median follow-up of 21 months, there were 27 deaths (55.3%). On univariate Cox regression analysis, New York Heart Association class>II, the left ventricular mass index (LV massi), the right ventricular ejection fraction (RVEF), the right ventricular end-systolic volume index (RVESVI) were associated with increased mortality. On multivariable Cox proportional analysis, only RVESVI was significantly associated with increased mortality (hazard ratio1.037, 1.001 to 1.075, p = 0.043). RVESVI had the better reliable diagnostic power for survival compared with NYHA class by ROC curves, with an area under the curve equal to 0.738.The receiver-operator characteristic curve-derived cut-off value of RVESVI of 32 mL/m2 predicted mortality, (x2: 10.084, P < 0.001).


Our data show that in patients with Cardiac Amyloidosis, the right ventricular end-systolic volume index is a powerful, independent predictor of longer-term survival. Cardiovascular magnetic resonance assessment of RV size is important in the evaluation and risk stratification of in these patients.

Author information

Authors and Affiliations


Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wan, K., Luo, Y., Yang, D. et al. The right ventricular end-systolic volume index predicts mortality in patients with cardiac amyloidosis. J Cardiovasc Magn Reson 18 (Suppl 1), P139 (2016).

Download citation

  • Published:

  • DOI: